Fatty acid composition in native and cultured human endothelial cells

Human umbilical vein endothelial cells (HUVECs) are frequently used in research to study vascular function. Prior research has shown that serum sources influence cell lipid composition. However, no prior work had resolved whether fetal bovine serum (FBS) or human serum (HS) affects phospholipid fatty acid profiles differently. This gap motivated an investigation into how serum type impacts fatty acid composition in cultured endothelial cells. It was already known that phospholipids contain essential polyunsaturated fatty acids (PUFAs), such as arachidonic acid. Yet, whether serum choice alters these levels remained unclear. The physiological role of arachidonic acid in prostacyclin synthesis made this question especially relevant. Cultured cells often differ from native cells in lipid composition. The uncertainty around serum effects on PUFA levels in endothelial cells created a need for direct comparison. This study aimed to clarify how FBS versus HS affects PUFA content in cultured endothelial cells.

This study sought to compare the fatty acid composition of cultured human endothelial cells with that of native cells. The specific problem was whether serum type—fetal bovine or human—alters phospholipid PUFA levels. The motivation stemmed from the importance of arachidonic acid in prostacyclin synthesis. Cultured cells may not reflect native cells accurately if serum affects lipid composition. The researchers aimed to determine whether FBS leads to lower PUFA levels compared to HS. They also wanted to assess if HS is a better serum source for preserving native-like lipid profiles. The study focused on phospholipid fatty acid changes in cultured cells. The goal was to provide data relevant to cell culture practices in vascular research.

Endothelial cells were isolated from human umbilical veins using collagenase treatment. Cells were cultured in media containing either 20% fetal bovine serum (FBS) or 20% human serum (HS). At confluency, cells were labeled with tritiated arachidonic acid to trace fatty acid incorporation. Lipids were extracted and separated into subclasses via thin layer chromatography. Fatty acid composition of each lipid class was analyzed using glass capillary gas-liquid chromatography. Native cells (NC cells) were compared to both FBS and HS cultured cells. The focus was on phospholipid fatty acid profiles, particularly PUFA levels. The comparison aimed to identify serum-dependent differences in lipid composition.

Phospholipid fatty acid composition differed between FBS-cultured cells and native cells. FBS cells showed reduced levels of polyunsaturated fatty acids (PUFAs), including arachidonic and linoleic acids. These were replaced by stearic and oleic acids in FBS cell phospholipids. No significant difference was observed between native cells and HS-cultured cells. The depletion of PUFAs in FBS cells suggests a serum-derived effect. FBS contains fewer PUFAs than HS, which may explain the observed changes. The replacement of PUFAs with saturated and monounsaturated fatty acids was specific to FBS cells. These findings highlight the impact of serum choice on cultured cell lipid profiles.

The authors propose that FBS may decrease PUFA levels in cultured endothelial cells. This may result from the lower PUFA content in FBS compared to HS. The observed changes in phospholipid composition were specific to FBS-cultured cells. No significant differences were found between native and HS-cultured cells. The study suggests that HS is a more suitable serum source for preserving PUFA levels. Arachidonic acid is essential for prostacyclin synthesis, making its preservation important. The findings imply that serum choice affects cultured cell lipid profiles. The authors conclude that HS cultivation may better reflect native endothelial cell lipid composition.